Recreational intercourse and Cannabis therapy go hand in hand.
Relax as your carer looks after all your terminal needs. Careers in caring are the new frontier for illegal healers.
Your income potential is still attached to your competence in dealing with the phone calls and death threats from the envious and dispossessed, but it’s probably easier than what you’re doing now. Can you care enough?
The Embassy Headlines are a selection of recent articles from news services and media sources primarily concerning Cannabis issues, the consequences of prohibition and the challenges for law reform. Here are the selected headlines for this week.
Tony Abbott Gives Medicinal Cannabis Trial In NSW The Green Light [Business Insider Australia]
Prime Minister Tony Abbott has thrown his support behind a trial of medical cannabis in NSW, with preparations for the trial to begin this week. While the federal regulator has approved the drug for use under certain medical circumstances, approval for importation of the plant from Europe or the US could take several weeks, in which case the NSW government says it may grow its own crop. Upon announcing the trial in September, NSW Premier Mike Baird said the government will also explore how to provide the safest and most effective cannabis-based products.
The NSW government says if it cannot source medical-grade cannabis from overseas, it may grow it in Australia.Children with severe epilepsy, terminally ill adults and those undergoing chemotherapy in NSW could get to trial cannabis to ease their symptoms. About $9m will be spent on at least three trials, some of which will be held at the Children’s hospital at Westmead and Sydney Children’s hospital. The NSW government says if it cannot source medical-grade cannabis from overseas, it is prepared to look at growing it here. “The government will assume responsibility for supply itself,” premier Mike Baird said. “If we have evidence that medical cannabis has the potential to change lives, then we need to do something about it.” Under new guidelines, police will have discretion to not charge terminally-ill cannabis users and the carers who assist them. “I am hopeful the trials will help us to better understand what role medical cannabis can play in alleviating symptoms in seriously ill patients, while the scheme will help to lighten the burden of stress for those suffering,” Baird said. An expert panel, led by NSW chief medical officer Dr Kerry Chant, will be established.
NSW Government could soon be growing pot for sick kids [Northern Star]
The NSW Government could soon be growing its own pot on behalf of sick children. In announcing a long-awaited trial of medical cannabis on Sunday, Premier Mike Baird said the Government was prepared to harvest its own if efforts to import the drug failed. The Government has earmarked $9 million for at least three separate trials to test whether cannabis-derived medical products can provide relief for patients, including one trial for children who suffer from a rare form of drug-resistant epilepsy. A Medical Cannabis Expert Panel led by NSW Chief Medical Officer Dr Kerry Chant will be formed to manage the trials. Mr Baird said the project would harness the expertise of NSW-based clinicians and researchers, alongside the latest research from across the globe. “Once we have the clinical evidence that medical cannabis can reduce suffering then the Government will consider a range of supply measures, including importation,” Mr Baird said. “But if that does not prove successful then the Government will assume responsibility for supply itself.” Health Minister Jillian Skinner said the trial for children would be run in partnership with leading epilepsy experts from The Children’s Hospital at Westmead and Sydney Children’s Hospital. “These experts will assess medicines derived from cannabis plants on the basis of the same risks and benefits as any other medicine,” Ms Skinner said. The Government will also invest in two further clinical trials for adults with terminal illness and those with chemotherapy-induced nausea.
Terminally ill adults who already use cannabis to alleviate their symptoms will be protected from prosecution in a scheme announced by Premier Mike Baird to coincide with the trial of medical cannabis. New guidelines will assist NSW Police officers in determining when and how to use their discretion not to charge adults with terminal illness who use cannabis, or the carers who assist them. To register for the Scheme, NSW residents aged 18 or over are required to have their terminal illness certified by a medical practitioner who is registered in Australia and involved in their ongoing care.
It appears to be just a matter of time before cannabis is legalised in some form within Australia, but state legislators are now faced with the choice of how far they should go. Victorian Premier Daniel Andrews has come forward with his desire to legalise medical cannabis in his state, while the NSW government is presiding over a medical trial in which marijuana is given to seriously ill people, including children suffering severe epilepsy. Mr Andrews said it was time to drag marijuana laws “into the 21st century. Parents shouldn’t have to choose between breaking the law and watching their children suffer,” he said. “Children are in pain, families are suffering, people are living in fear and outdated laws are getting in the way.” Canberra’s Calvary Hospital emergency department head David Caldicott has backed attempts to legalise medical cannabis, but senior doctors who back full legalisation are difficult to find, with doctors warning of the dangers of street marijuana.
Daniel Andrews aims to make Victoria the first Australian state to legalise medicinal cannabis [Nine News]
Newly-elected Victorian Premier Daniel Andrews is leading the charge on medicinal cannabis, hoping to legalise the drug for patients in need by the end of 2015. Products such as cannabis oil are used to treat conditions including epilepsy and provide relief from suffering for some cancer patients. However, the plant remains illegal throughout Australia, and Mr Andrews said on the TODAY Show he was determined to see that change.
Buying drugs online: NSW lawyers ‘radical proposal’ to decriminalise drugs[Sydney Morning Herald]
A teenager on Sydney’s northern beaches orders cocaine online and has it posted to their front door. It is just one of the signs that existing drug laws have “substantially failed”, according to top criminal barristers in NSW. The NSW Bar Association’s criminal law committee, chaired by Sydney barrister Stephen Odgers SC, has put forward a “radical proposal” to replace the black market for drugs with a highly-regulated system of legal availability. The committee says existing laws aimed at curbing illicit drug use and supply are not working and are resulting in “considerable” harm including an unregulated black market, drug overdoses, and crimes such as prostitution and armed robbery that are committed to pay for drugs. It says its preliminary view, subject to further research and consultation, is that the current prohibitionist approach to drugs should be abandoned and replaced with a tightly-regulated system where drugs are legally available. The system might involve licensing controls on the production and supply of drugs, along with price regulation and comprehensive services for treating drug addiction. A ban on private trafficking, supply to children and advertising was also flagged by the committee. The committee is made up of heavy-hitters who both prosecute and defend people accused of drug-related crimes, including former Director of Public Prosecutions Nick Cowdery QC, and highly respected silks Tim Game, John Stratton, and Gaby Bashir. It wants the community to engage in an informed debate about drug law reform, as the state government comes under increasing pressure to convene a drug summit to tackle the issues. The Bar Association will also hold a conference on drug law reform on May 29.
Criminal lawyers see the harm caused by illicit drugs, particularly to dependent users. Yet we also see the harm caused by the current prohibitionist model with its heavy reliance on the criminal law to deter drug use. We see the scale of the black market, the enormous profits made by drug importers and manufacturers and the violence committed by those determined to share in those profits. We have known users who obtained drugs from the black market and then died from overdoses or contaminants. We have seen users who become small-time dealers to meet their drug needs and then end up in prison for dealing. We know users who have resorted to property crime to pay for drugs from those drug dealers. Which is why we believe a drug summit needs to be called to address these issues in NSW.
Tasmanians who use medicinal cannabis for a serious illness want the State Government to guarantee they will not be prosecuted for its use and cultivation. Launceston woman Lyn Cleaver has been growing a cannabis plant to make medication for her son Jeremy, 23, who suffers from severe epileptic seizures. When the Tasmanian Government ruled out decriminalising medicinal cannabis, outspoken medicinal users of the drug were assured they would not be prosecuted. Ms Cleaver kept her illegal crop secret until today when she called Tasmania Police and told them about the plant.
This month the Drug Policy Alliance (DPA) published a pamphlet that urges producers of raves, concerts, and music festivals to take common-sense measures aimed at reducing the harm caused by drug use at their events. “A pragmatic approach to managing drug use at events can save lives,” DPA notes. Since overheating and dehydration are well-recognized hazards for people dancing at crowded musical venues, especially if they have taken MDMA or other drugs that raise body temperature, why not offer free water and space for cooling off? What not have counselors on site to help drug users through bad trips? Why not welcome harm reduction groups like DanceSafe that can provide accurate information about the effects of various drugs and test samples so people have a better idea of what they’re actually consuming?
Cannabis: Nebraska and Oklahoma sue Colorado [Telegraph UK]
Heartland states challenge legalisation of cannabis in Colorado as pot backlash intensifies. Colorado’s decision to legalise pot following a voter referendum has come under challenge from Nebraska and Oklahoma. The two states are asking the Supreme Court to shut down the recreational marijuana stores that have mushroomed in Colorado since the pot was legalised. But the move by Nebraska and Oklahoma reflects part of a growing backlash against the liberalisation of the law. Now Nebraska and Oklahoma, which both share a border with Colorado, want to go further and overturn the liberal marijuana laws. They have told the Supreme Court that there has been an influx of marijuana into their territory, putting strain on local law enforcement budgets following a surge in cannabis-related arrests. Marijuana remains illegal under federal law and the Nebraska and Oklahoma have said legal pot sales in Colorado amount to “irreparable injury”. “We’re seeing a lot of marijuana coming over from Colorado,” said Sheriff Adam Hayward of Deuel County, Nebraska told the New York Times. “For the longest time we were saying, this is becoming a problem for us.” However the Marijuana Industry Group has warned that overturning the Colorado law could backfire. “Coloradans overwhelmingly voted in favour of legalising marijuana,” it said. “In so doing, we’ve chosen the licensed and regulated marijuana businesses over violent criminal organisations. The licenced marijuana businesses have embraced licencing, regulations, increased taxes, and strict enforcement. If Nebraska and Oklahoma succeed, they will put the violent criminal organisations back in charge.” John Suthers, Colorado’s Attorney General, also dismissed the lawsuit, describing it as being “without merit”. “Because neighbouring states have expressed concern about Colorado-grown marijuana coming into their states, we are not entirely surprised by this action,” he said in a statement. “However, it appears the plaintiffs’ primary grievance stems from non-enforcement of federal laws regarding marijuana, as opposed to choices made by the voters of Colorado.”
We can opine anecdotally on how legal marijuana sales changed Colorado in 2014, and we’ve done just that recently — read my “year in the life of the world’s first marijuana editor” essay here. But since we’re journalists we also track down the hard numbers that show legal marijuana’s definitive impact on the state in this first year of recreational pot sales. And a glance at the numbers, statistics and calculations below will give you a very clear picture of what legal, regulated, first-of-its-kind marijuana looks like in the Rocky Mountains.
1. 130.3 metric tons: That’s Colorado’s annual demand for marijuana — equal to 36.8 million “eighths” of cannabis flower.
2. 485,000: That’s the number of adults who are 21 and older using marijuana regularly (at least once a month), and it’s about 9 percent of the state’s population.
3. 23 %: That’s the amount of Colorado’s user population that consumes cannabis near daily.
4. 90 %: That’s the amount of recreational pot sales out-of-state tourists are responsible for at shops in mountain resort communities.
5. 7 %: That’s the amount of Colorado’s annual pot demand purchased by out-of-state tourists.
6. -9 %: That’s the price drop on a recreational eighth of marijuana flower at a dozen prominent Colorado pot shops from January 2014 ($53.88) to December 2014 ($48.95).
8. $326,716,273.59: That’s Colorado’s total medical marijuana sales, also from January to October. (Yep, that’s $573,526,872.62 in 10 months for both recreational and medical pot sales in Colorado.)
9. 103,918L That’s the number of medical marijuana patients reporting “severe pain” as their condition for a license — or 94 percent of the state’s total patients.
10. $60.1 million: That’s the amount Colorado has brought in via taxes, licenses and fees on recreational and medical marijuana, from January to October.
11. 10 milligrams of THC: That’s the state-standard single-serving size for marijuana edibles, with 100 milligrams maximum allowed in an individually packaged product being sold recreationally.
12. Zero: Thats’ the number of reports of THC-laced candy given to trick-or-treaters on Halloween, regardless of widespread concern that legal marijuana would lead to pot-laced candies in children’s Halloween hauls.
Pot Pie, Redefined? Chefs Start to Experiment With Cannabis [New York Times]
Recreational marijuana is both illegal and controversial in most of the country, and its relationship to food does not rise much above a joke about brownies or a stoner chef’s late-night pork belly poutine. But cooking with cannabis is emerging as a legitimate and very lucrative culinary pursuit. In Colorado, which has issued more than 160 edible marijuana licenses, skilled line cooks are leaving respected restaurants to take more lucrative jobs infusing cannabis into food and drinks. In Washington, one of four states that allow recreational marijuana sales, a large cannabis bakery dedicated to affluent customers with good palates will soon open in Seattle. Major New York publishing houses and noted cookbook authors are pondering marijuana projects, and chefs on both coasts and in food-forward countries like Denmark have been staging underground meals with modern twists like compressed watermelon, smoked cheese and marijuana-oil vinaigrette. “It really won’t be long until it becomes part of haute cuisine and part of respectable culinary culture, instead of just an illegal doobie in the backyard,” said Ken Albala, director of the food studies program at the University of the Pacific in San Francisco.
Study: Evidence Fails to Support DUI Impairment Levels for Cannabis [The joint Blog]
Available science fails to support the imposition of driving under the influence (DUI) impairment thresholds for cannabis in a manner that is analogous to the per se limits already in place for alcohol, according to the conclusions of a November 2014 publication published by the United States Department of Transportation, National Highway Traffic Safety Administration (NHTSA). Per se traffic safety laws criminalize those who operate a vehicle with trace or specific levels of a controlled substance in their bodily fluids, even in the absence of any further evidence indicating that the subject was behaviorally impaired. States the paper’s authors, “Every state has enacted a law defining drivers who are at or above .08 grams per deciliter BAC as ‘legally impaired,’ but there are no similar, commonly accepted impairment levels for other drugs.” Nonetheless, despite this lack of consensus, authors acknowledge that “some state laws have established levels for some drugs at which it is illegal to operate a motor vehicle” – a position which they concede is not evidence based. “The alcohol laws are based on evidence concerning the decreased ability of drivers across the population to function safely at these BACs,” they write. “Such evidence is not currently available for concentrations of other drugs.”
Study looks at marijuana’s impact on brain [USA Today]
Though marijuana is the most commonly used illegal drug in the country, little is definitively known about its impact on the brain. A study taking place at Indiana University is designed to help change that. Clinical psychologist Brian O’Donnell and colleague Sharlene Newman are recruiting current and former marijuana users to participate in a study in which their brains will be analyzed for changes in structure and function. “From animal studies, there’s reason to believe it (marijuana use) will affect parts of the brain and also the connections between them, and some of our preliminary studies suggest that is the case,” said O’Donnell, a professor in the department of psychological and brain sciences. The study — funded by a $275,000 grant from the National Institutes of Health — is taking place as marijuana gains acceptance in some parts of the country. Marijuana has been legalized for recreational use in Colorado, Washington state, Alaska and Oregon, and many states now have medical marijuana programs, according to the National Conference of State Legislatures.
Drug Maker Will Soon Hold Patent On THC, CBD As Cancer Cures [Medical Marijuana 411]
GW Pharmaceuticals, a drug company that specializes in cannabis-based pharmaceuticals, has received early approval on a patent covering the use of marijuana chemicals for treating brain cancer.GW Pharmaceuticals announced Wednesday that it has been issued a Notice of Allowance from the U.S. Patent Office for a patent application involving the use of THC and CBD, the two main chemicals in marijuana, for treating gliomas. Once a patent application is deemed a genuine invention, the Patent Office sends a Notice of Allowance that outlines the fees involved with final approval.Specifically, the company provides this description of the patent: “The subject patent specifically covers a method for treating glioma in a human using a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) wherein the cannabinoids are in a ratio of from 1:1 to 1:20 (THC:CBD) with the intent to reduce cell viability, inhibit cell growth or reduce tumor volume.”
AAN urges for more research on use of medical marijuana for brain, nervous system disorders [News Medical]
The American Academy of Neurology (AAN) is calling for more research on the use of medical marijuana for brain, spine and nervous system disorders in a new position statement released by the AAN, the world’s largest association of neurologists with more than 28,000 members. “The current medical marijuana legislation being passed by policymakers across the country, which promotes marijuana-based products as treatment options for various brain and nervous system disorders, is not supported by high-level medical research,” said position statement author Anup Patel, MD, with Nationwide Children’s Hospital in Columbus, Ohio, and a member of the AAN. “There may be some safety concerns for marijuana-based products, especially for long-term use in patients with these diseases, as to date it has not been well-studied.” The AAN supports the reclassification of marijuana-based products by the federal government from their current status as a Schedule I drug to improve access for study of marijuana or cannabinoids under approved research protocols.
9 Facts About Canada’s New Medical Marijuana System [Marijuana Patients]
Here are some facts about Canada’s medical marijuana system, which was overhauled earlier this year as the federal government moved production out of basements and into commercial facilities:
The old system: Patients who received authorization from the federal government had the option of growing their own marijuana, designating someone else to grow it for them, or ordering the drug directly from Health Canada. Patients buying marijuana from Health Canada had access to a single strain of the drug, which sold for $5 per gram.
Number of authorizations under previous regime: About 38,000.
The new system: Home growing is prohibited, and instead patients are required to order from a licensed commercial producer.
The court challenge: A group of patients is preparing to challenge the new regime in Federal Court, with a trial set for the new year. In the meantime, an injunction has allowed patients who were authorized under the old system.
Producers licensed to sell marijuana: 15, including seven in Ontario; five in B.C.; and one each in Saskatchewan, Manitoba and New Brunswick.
Patients registered under the new system: 13,671, as of Oct. 31.
Amount of marijuana sold by licensed producers: About 1,400 kilograms between Jan. 1 and Oct 31.
Price: It ranges from $2.50 per gram to as high as $15, depending on the producer and the strain, but most are between $8 and $10.
Applications: Health Canada has received more than 1,100 applications from prospective producers. Of those, almost 600 have been returned as incomplete, more than 200 have been rejected and 35 were withdrawn. As of Nov. 24, Health Canada was still reviewing 301 applications, 13 of which were awaiting a pre-approval inspection — the final step before approval.
I have been busy as ever spreading the DrugScience message. Outside of regular talks at universities and six-forms, highlights include the Intoxication Season lecture series at Kew Gardens, where Drugscience was also represented by Val Curran and Josh Hulbert, who talked about cannabis research, health risks, policy and the future of cannabinoid therapeutics. The Mail on Sunday tried and failed to create a furore about the events for daring to engage the public’s imagination beyond a ‘drugs are evil’ message, but they helped my talk sell out within a couple of hours! I also spoke at Festival Number 6 in Portmerion Snowdonia, a magnificent location for a wonderful festival of music poetry and some talks. Thanks to the Salon Project for that. In July I helped launch the United Patients Alliance campaign for medical cannabis by speaking on a platform in Brighton with the Green MP Caroline Lucas, an impressive, open minded and committed representative of her constituency. The call for medical cannabis is growing louder each day as the lessons from the USA experience are being learnt and the iniquity of UK patients being denied access to effective treatment become clearer. It is estimated at least 30,000 people use cannabis daily for medical purposes and each run the risk of convictions to them and their carers for no end. I visited two islands this summer – the Isle of Man and Iceland- and in both gave public lectures to help the locals in their attempts to develop a more sensible policy on drugs. The Isle of Man offers the potential for pioneering medical cannabis availability in the British Isles and serious discussion is now going on. The Iceland talk is online. A new society for Psychedelics was launched in London on the 3rd Nov and I spoke at the opening about my research.
‘Bliss molecule’ similar to THC in cannabis found in expensive black truffles dug out by pigs [The Independent UK]
Black truffles sniffed out of the ground by pigs and dogs due to their attractive earthy and cocoa-like aroma contain a “bliss molecule” similar to THC found in cannabis, scientists have found. A compound called anandamide, which triggers the release of feel-good chemicals in the brain, is produced by the fungi also known as Tuber melanosporum, research from an Italian university has revealed. The expensive and rare black truffles grown in mainly European countries such as France and Spain, which are used as garnish shavings over gourmet food and in luxury chocolates, currently cost around £195 per 100g.
UK doctors given go-ahead to begin testing treatment derived from cannabis plant. Children with severe epilepsy could be helped by a new treatment derived from the cannabis plant. Doctors in the UK have been given the go-ahead to test the medicine, which does not contain the ingredient that produces the high associated with recreational cannabis use. The treatment – called Epidiolex – is based on one of the non-psychoactive components of the cannabis plant, called CBD. Early studies in the US have shown that treatment with CBD may reduce the frequency and severity of seizures in children with severe forms of epilepsy. The new trial marks the first time the treatment has been tested in the UK. Patients are being enrolled for a randomised controlled trial of the treatment at The University of Edinburgh’s Muir Maxwell Epilepsy Centre, based at the Royal Hospital for Sick Children in Edinburgh, and Great Ormond Street Hospital. The Royal Hospital for Sick Children in Glasgow and Alder Hey Children’s Hospital in Liverpool are also driving the study. There are further centres in the US, France and Poland.
An Open Letter To Russell Brand… [Students for Sensible Drug Policy UK]
Having watched your recent BBC documentary End the Drugs War, we felt that it was necessary to address some of the points and messages contained within the programme. While you make some very good points which we would agree with, there are other areas of the programme which can be potentially damaging to the drug policy reform movement, as well as to the people who use drugs you feature in your programme. While we agree that the War on Drugs needs to end, and that criminalising drug users is counterproductive, even harmful to drug users and wider society, we feel that you give a very narrow view of drug dependency based on your own individual experience, and haven’t fully addressed or portrayed the complexity of drug use and the many factors which contribute to, and perpetuate drug-related problems. One of the most problematic points for us is your portrayal of both ‘addiction’ and the ‘drug addicts’ featured in your programme, as well as your assertion that abstinence-based treatment is exclusively the way to manage and help those who are experiencing drug-related problems. Whilst we do not demean your personal experiences with drugs, we do however question your presumption that everyone who uses drugs would benefit from this approach. For example, there is evidence that many people’s recoveries from alcohol abuse conclude with moderate, non-problematic drinking rather than total abstinence. These people have reported experiencing problems with the spiritual focus of the 12-step program, a widely advocated and significant part of the abstinence movement.
What We Learned About Drugs in 2014 [Vice UK]
Propaganda, myths or completely making things up are all de rigueur when it comes to drug stories. This year we’ve been told that cannabis is as addictive as heroin, Stephen Fry is responsible for the misery in Mexico and that Breaking Bad created a crystal meth epidemic in Europe. In the drug zone, everyone is under some kind of influence, whether it’s journalists with an agenda to chase or scaremongering politicians with votes to win. Or you. On drugs. So, for some end-of-year clarity, here is your scratch ‘n’ sniff guide to what really went down in the world of drugs in 2014.
- THE ‘CELEB DRUG DEALER’ STING IS DEAD
- CAPITALISTS HAVE HIJACKED THE DRUG REVOLUTION
- BRITAIN IS DRIFTING IN A SEA OF POTENT E
- THE GOVERNMENT CAN’T USE FALLING DRUG USE AS PROOF THAT ITS DRUG POLICY IS WORKING—BECAUSE IT’S STARTED RISING AGAIN
- KETAMINE’S DARK SIDE
- IN THE UK, DRUG TAKERS ARE STILL HATED
- THE DRUG-SEX CRIME HORRORS HAVE NOT LET UP
- SHITTY SYNTHETIC WEED HAS LEFT OUR PRISON SYSTEM IN MELTDOWN
Of all the drugs set to flood the bloodstreams of New Year’s Eve revelers, virtually nobody will be riding high on one called “chaperon.” Most have never heard of it, nor will they care to — at least, not with all those lavish sums of booze and MDMA available to ingest tonight. “Chaperon” is the shadowy newcomer to the designer drug game, and its psychotropic effect is meant to disguise a secret role as a “binge mitigation agent.” Originally intended to be sold as a legal way to roll balls, its creator now plans to hand over the patent to DrugScience, a harm reduction organization. Courtesy of the guy who brought us mephedrone (one of the now-banned bath salts impersonating molly in all of those shady baggies floating around), this latest endeavor by “Dr. Z” looks to give its takers a boozy, euphoric ride — without the actual booze and molly. Based on the limited, non-scientific test drive taken by Michael Slezak at New Scientist, chaperon gives users an “intense” ecstasy-like rush to accompany a quasi-drunk state that also kills the thirst for alcohol. As many well know by now, the appeal of alcohol and molly’s synergy is also what makes it so deadly. After all, alcohol did have a hand in 3.3 million deaths in 2012, while MDMA has become a recurring culprit in a never-ending string festival overdoses in recent years. Neither lend themselves well to moderation, especially not while taken together. But where awkward PSA’s and fearmongering have failed to suffocate a problem out of existence, chaperon heeds the primal call to party, but in a way that mitigates risks — death, for instance. So if nothing else, think of it as the condom of recreational drug use, a buffer against our uncrushable drive to do regrettable shit we know we shouldn’t yet still do anyways. Even if it does become illegal — as it almost certainly will — perhaps it’s a safer pathway worth exploring.
This is the first book since DM Turner’s classic work ‘The Essential Psychedelic Guide’, to be a general book about psychedelics. Drawing upon 15 years of profound research, Articulations is an illuminating inquiry into the many different plants and compounds available in the modern day, conducive ‘mindsets’ and understandings regarding how psychedelics can be most constructively utilised. Articulations presents an uncompromising and clear analysis of the psychedelic state, intricately exploring the origins of the visions, the nature of the beings, and how authentic healing can most effectively proceed through the conscious use of psychedelics.